CS logo
small CS logo
Gansu Wuwei Tumor Hospital

Wuwei, Gansu, China

About Gansu Wuwei Tumor Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Gansu Wuwei Tumor Hospital


During the past decade, Gansu Wuwei Tumor Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Gansu Wuwei Tumor Hospital" #1 sponsor was "Hepatopancreatobiliary Surgery Institute of Gansu Province" with 2 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored, "Shanghai Henlius Biotech" with 1 trials sponsored, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials sponsored and "Taizhou Hanzhong biomedical co. LTD" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

Clinical Trials Conditions at Gansu Wuwei Tumor Hospital


According to Clinical.Site data, the most researched conditions in "Gansu Wuwei Tumor Hospital" are "Advanced Hepatocellular Carcinoma (HCC)" (1 trials), "Advanced Non-squamous Cell Non-small Cell Lung Cancer" (1 trials), "Cholecystitis" (1 trials), "Gallstones" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Gansu Wuwei Tumor Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Gansu Wuwei Tumor Hospital


Most popular intervention types in "Gansu Wuwei Tumor Hospital" are "Drug" (4 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Anlotinib hydrochloride capsule" (1 trials), "Carboplatin injection" (1 trials), "ERCP" (1 trials) and "HLX07" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Gansu Wuwei Tumor Hospital


The vast majority of trials in "Gansu Wuwei Tumor Hospital" are 6 trials for "All" genders.

Clinical Trials Status at Gansu Wuwei Tumor Hospital


Currently, there are NaN active trials in "Gansu Wuwei Tumor Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gansu Wuwei Tumor Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Gansu Wuwei Tumor Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".